Related Experiment Video
Updated: Nov 15, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Human immunodeficiency virus (HIV) and coronavirus disease 2019; impact on vulnerable populations and harnessing
A Cordie1, M AbdAllah2, A Vergori3
1Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Insights
Coronavirus disease 2019 (COVID-19) negatively impacts people with human immunodeficiency virus (HIV) by worsening their health and disrupting HIV care. Vulnerable groups like pregnant women and the LGBTQI+ community require special attention during the COVID-19 pandemic.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) presents a significant challenge to global health management.
- People living with human immunodeficiency virus (HIV) are a vulnerable population susceptible to severe outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
- The COVID-19 pandemic can impede essential HIV prevention and treatment services, particularly in resource-limited settings.
Purpose of the Study:
- To examine the dual impact of COVID-19 on individuals living with HIV and on national HIV control programs.
- To highlight the heightened risks faced by specific populations, including pregnant women and the LGBTQI+ community.
- To emphasize the need for coordinated efforts from governmental and non-governmental organizations.
Main Methods:
- This study is a review and analysis of existing literature and public health data.
- It synthesizes information on the physiological and psychological vulnerabilities of people with HIV during SARS-CoV-2 infection.
- It assesses the impact of COVID-19 on HIV care delivery, linkage, and prevention strategies.
Main Results:
- People with HIV may experience more severe illness when infected with SARS-CoV-2 due to underlying vulnerabilities.
- The pandemic has strained healthcare systems, potentially limiting access to and continuity of HIV services.
- Disruptions disproportionately affect low- and middle-income countries and specific high-risk groups.
Conclusions:
- COVID-19 poses a dual threat to individual health outcomes for people with HIV and the effectiveness of public health interventions for HIV.
- Targeted strategies and increased support are crucial for pregnant women and the LGBTQI+ community to mitigate adverse outcomes.
- Collaborative action between governmental and non-governmental organizations is essential for maintaining and improving HIV management during the pandemic.
Abstract:
Coronavirus disease 2019 (COVID-19) can act as a dual prong attack against management of people living with human immunodeficiency virus (HIV); it induces harm on both individual and national levels. People living with HIV may show rapid deterioration in severe acute respiratory syndrome coronavirus 2 infection as a result of physiological or psychological vulnerability. Additionally, the spread of COVID-19-especially in low- and middle-income countries-may limit HIV control measures, delivery and linkage to HIV care and prevention. Attention should be given to pregnant women and the LGBTQI+ community for their higher susceptibility to poor outcomes. Engagement of both governmental and non-governmental organizations is encouraged for better results.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Viral Mutations
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

